Projects per year
Personal profile
Biography
Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Currently he is also Director, Lung & Sleep Medicine, Monash University and Medical Centre, Melbourne.
He is recognised for investigation of obstructive lung diseases (particularly virusasthma-COPD exacerbations) and has conducted extensive research of new asthma and COPD therapies. Recently research has examined vocal cord dysfunction in obstructive lung diseases. Professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD.
He is a recipient of ongoing Australian NH&MRC funding, has chaired the Australian NH&MRC Grant Review Panel (Respiratory & Sleep Medicine) and served on the Australian NH&MRC Academy. Currently he is Co-Editor of Respirology, official journal of the TSANZ and APSR.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, FRACP, Royal Australasian College of Physicians (RACP)
Award Date: 1 Jan 2003
PhD, University of Southampton
Award Date: 1 Jan 1994
Medicine, FCPSA, Colleges of Medicine of South Africa
Award Date: 1 Jan 1985
External positions
Co-Editor in Chief, Monash Health
1 Jan 2017 → …
Director Monash Lung and Sleep, Monash Health
1 Mar 2012 → …
Research area keywords
- COPD
- Asthma
- Laryngeal dysfunction
- immunology
- Inflammation
- exacerbation
- bacterial respiratory disease
- virus pathogenesis
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 2a, Randomized, Double-Blind, Parallel-Group,Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fexlamose (AER-01) Inhalation Solution in the Treatment of Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease
Bardin, P. (Primary Chief Investigator (PCI))
8/04/25 → 10/04/30
Project: Research
-
CARISTA: Creating A RIsk assessment biomarker Tool to prevent Seasonal allergic and Thunderstorm Asthma
Douglass, J. A. (Primary Chief Investigator (PCI)), Lowe, A. J. (Chief Investigator (CI)), Thien, F. (Chief Investigator (CI)), Bardin, P. (Chief Investigator (CI)), Lampugnani, E. (Chief Investigator (CI)), Sanci, L. (Chief Investigator (CI)), Davies, J. M. (Chief Investigator (CI)), Rees, M. (Chief Investigator (CI)) & Vicendese, D. (Chief Investigator (CI))
1/03/24 → 28/02/29
Project: Research
-
A 52-week, randomized, double-blind, placebo-controlled, parallel-group, study to evaluate the efficacy and safety of two doses of CHF6001 DPI add-on to maintenance triple therapy in subjects with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
Bardin, P. (Primary Chief Investigator (PCI))
23/06/23 → 13/06/28
Project: Research
-
BURAN: BURAN: Effects of BenralizUmab on AiRwAy DyNamics in Severe Eosinophilic Asthma patients using Functional Respiratory Imaging Parameters
Bardin, P. (Primary Chief Investigator (PCI))
29/05/23 → 28/05/28
Project: Research
-
A Phase 2, Randomised, Double-Blind, Placebo and Active Comparator-Controlled Study to Assess Efficacy and Safety of Mulitiple Dose Levels of AZD5718 Given Orally Once Daily for Twelve Weeks in Adults with Moderate-to-Severe Asthma
Bardin, P. (Primary Chief Investigator (PCI))
3/05/23 → 2/05/28
Project: Research
-
A Global Achievement: Introducing the Inducible Laryngeal Dysfunction/Vocal Cord Dysfunction Toolkit—A Free Global, Peer-Reviewed Clinical Resource
Leong, P., Clark, V. L., Gibson, P. G., McDonald, V. M. & Bardin, P. G., Jun 2025, In: Respirology. 30, 6, p. 537-538 2 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access -
AI as a tool to repurpose existing compounds for respiratory indications
Bardin, P. G. (Leading Author), Thomas, B. J. & Bourke, J. E., Sept 2025, In: The Lancet Respiratory Medicine. 13, 9, p. 781-782 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
-
Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma
Jones, A. W., McDonald, V. M., McLoughlin, R. F., Vella, T. M., Flynn, A. W., Blakey, J. D., Wolfenden, L., Hew, M., Upham, J. W., Thomas, D., Bardin, P. & Holland, A. E., 2025, In: Patient Preference and Adherence. 19, p. 75-85 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Thomas, D., McDonald, V. M., Stevens, S., Harvey, E. S., Baraket, M., Bardin, P., Bowden, J. J., Bowler, S., Chien, J., Chung, L. P., Gillman, A., Hew, M., Hodge, S., James, A., Jenkins, C., Katelaris, C. H., Katsoulotos, G. P., Langton, D., Lee, J. & Marks, G. & 9 others, , Feb 2024, In: Allergy. 79, 2, p. 384-392 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access60 Citations (Scopus) -
Dysfunctional breathing or breathing pattern disorder: New perspectives on a common but clandestine cause of breathlessness
Ruane, L. E., Denton, E., Bardin, P. G. & Leong, P., Oct 2024, In: Respirology. 29, 10, p. 863-866 4 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access5 Citations (Scopus)